(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Corvus Pharmaceuticals is 345270
| Date | Daily Closing Price | Open | High | Low | Volume |
| 08 Wed May 2024 | 1.96 | 1.87 | 2.00 | 1.83 | 1.907 times |
| 07 Tue May 2024 | 1.68 | 1.81 | 1.94 | 1.43 | 2.948 times |
| 06 Mon May 2024 | 1.91 | 2.09 | 2.09 | 1.83 | 3.042 times |
| 03 Fri May 2024 | 1.92 | 1.81 | 2.08 | 1.75 | 1.103 times |
| 02 Thu May 2024 | 1.73 | 1.76 | 1.78 | 1.68 | 1.313 times |
| 01 Wed May 2024 | 1.61 | 1.53 | 1.65 | 1.51 | 0.233 times |
| 30 Tue Apr 2024 | 1.55 | 1.60 | 1.60 | 1.53 | 0.164 times |
| 29 Mon Apr 2024 | 1.58 | 1.48 | 1.61 | 1.44 | 0.382 times |
| 26 Fri Apr 2024 | 1.45 | 1.56 | 1.62 | 1.44 | 0.36 times |
| 25 Thu Apr 2024 | 1.48 | 1.47 | 1.52 | 1.41 | 0.192 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 2, for a target of 1.8 or 1.58
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.39 |
| Downside Target | 1.43 |
| Downside Target | 1.54 |
| Downside Target | 1.62 |
| Downside Target | 1.71 |
| Downside Target | 1.79 |
| Downside Target | 1.94 |
| Upside Target | 2.08 |
| Upside Target | 2.09 |
| Upside Target | 2.34 |
| Upside Target | 2.42 |
| Upside Target | 2.58 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 1.56 |
| Downside Intraday Target | 1.17 |
| Upside Intraday Target | 2.22 |
| Upside Intraday Target | 2.49 |
| Downside Intraday Target | 1.83 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 08 Wed May 2024 | 1.96 | 2.09 | 2.09 | 1.43 | 2.472 times |
| 03 Fri May 2024 | 1.92 | 1.48 | 2.08 | 1.44 | 2.009 times |
| 26 Fri Apr 2024 | 1.45 | 1.39 | 1.62 | 1.39 | 1.162 times |
| 19 Fri Apr 2024 | 1.40 | 1.53 | 1.54 | 1.30 | 0.572 times |
| 12 Fri Apr 2024 | 1.53 | 1.75 | 1.79 | 1.46 | 0.73 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 08 Wed May 2024 | 1.96 | 1.53 | 2.09 | 1.43 | 1.15 times |
| 30 Tue Apr 2024 | 1.55 | 1.78 | 1.94 | 1.30 | 0.663 times |
| 28 Thu Mar 2024 | 1.78 | 2.25 | 2.34 | 1.71 | 1.061 times |
| 29 Thu Feb 2024 | 2.24 | 2.00 | 2.58 | 1.94 | 1.036 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.8 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Corvus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Corvus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.8 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.